HAE
Haemonetics Corp (HAE)
Healthcare • NYSE • $55.12+1.38%
- Symbol
- HAE
- Exchange
- NYSE
- Sector
- Healthcare
- Industry
- Medical Devices
- Price
- $55.12
- Daily Change
- +1.38%
- Market Cap
- $2.56B
- Trailing P/E
- 15.18
- Forward P/E
- 9.51
- 52W High
- $87.32
- 52W Low
- $47.32
- Analyst Target
- $81.10
- Dividend Yield
- N/A
- Beta
- 0.53
Haemonetics Corporation, a medical technology company, provides a suite of hospital technologies solutions in the United States and internationally. The company offers automated plasma collection systems, donor management software, and supporting software solutions, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLynk DMS donor management system and Donor360 tools. It also provides treatment in electrophysiology, critical care, neurocritical care, trauma, burn surgery, spine surgery, and cancer surgery; SavvyWire, a sensor-guided 3-in-1 guidewire for TAVR procedures; and OptoWire, a pressure guidewire that mea…
Company websiteResearch HAE on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.